Since the mutation from phenylalanine to leucine at the 450th position of the NP protein resulted in a 104−5-fold increase in TCID50 value for the non-oncolytic I4, this site was defined as the major determinant of NDV’s differential infectivity in tumor cells (Fig 3I–3N). This evidence concerns the gene KLK8 and neoplasm.